Fujifilm has announced that its Diosynth Biotechnologies in the UK will make the Novavax COVID-19 vaccine.

Work at its plant in Billingham, Stockton-on-Tees, will employ more than 300 and start this month, with workers making more than 60 million doses. The plant - at which 800 work - makes wideformat printers, inks and piezo printheads, as well as offset plates and chemistry.

Novavax, which is based in Maryland, USA, is to supply 51 million doses of the vaccine to Australia and 10.7 million for New Zealand, Wideformat Online magazine has reported.